Eupraxia Pharmaceuticals Inc. (EPRX) bonds
EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.62−0.72 (-9.81%)
Close on Nov 17, 2026Market cap $399.15MP/E –Yield –
Debt
Borrowings on the balance sheet, Dec 31, 2025
Eupraxia Pharmaceuticals reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Eupraxia Pharmaceuticals's 40-F for the period ended Aug 1, 2024
Eupraxia Pharmaceuticals's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Convertible Debt Facility | C$12.00M |
See a number that looks wrong?